GISTT RACE · Research Alliance for CurE

Governance

GISTT-RACE aims for a lean structure and a governance that adapts to the needs of achieving a cure.

Interim governance. The final governance will be decided at a general assembly during the GISTT Summit 2027 in Edinburgh. Until then, the interim governance shown below applies.

Supervisory Board

  • FCSenior Executive Advisor
  • Deke GeorgeSenior IT/AI Advisor
  • Jonathan DavidSenior Legal Advisor

Operational Office and teams

Operational Office

  • Sebastian BauerCo-Chair
  • Jonathan FletcherCo-Chair
  • Johanna FalkenhorstScientific Coordinator
  • Julia KetzerLead Project Management

Project Management

  • Julia KetzerLead Project Management
  • Mourad BarakatProject Assistant

Registry Coordination

  • Johanna FalkenhorstScientific Coordinator
  • Rainer SchmedingData Management

IT-Infrastructure

  • Dawid Krzeciesa

Public Relations

To be announced

Industry Liaison

To be announced

Scientific boards

Research Advisory Board

22 membersScientific direction and prioritization along the central questions.
  • Cristina AntonescuMemorial Sloan Kettering Cancer Center
  • Ping ChiMemorial Sloan Kettering Cancer Center
  • Jean-Michel CoindreInstitut Bergonié
  • Ron DeMatteoUniversity of Pennsylvania
  • Armelle DufresneCentre Léon Bérard
  • Suzanne GeorgeDana-Farber Cancer Institute
  • John GlodNational Cancer Institute, NIH
  • Candace HaddoxDana-Farber Cancer Institute
  • Alessandro GronchiFondazione IRCCS Istituto Nazionale dei Tumori, Milan
  • Michael C. HeinrichOHSU Knight Cancer Institute
  • Peter HohenbergerUniversity Medical Center Mannheim, Heidelberg University
  • Robin JonesThe Royal Marsden and The Institute of Cancer Research, London
  • Adrian Mariño-EnriquezUniversity College Dublin
  • Toshi NishidaJCHO Osaka Hospital
  • Wenbin OuZhejiang Sci-Tech University
  • Lori RinkFox Chase Cancer Center
  • Piotr RutkowskiMaria Sklodowska-Curie National Research Institute of Oncology
  • Min-hee RyuAsan Medical Center
  • César SerranoVall d’Hebron Institute of Oncology
  • Jason K. SicklickUC San Diego
  • Andrew WagnerDana-Farber Cancer Institute
  • Eva WardelmannUniversity Hospital Münster

Project-related scientific boards

Each project has its own scientific board and participating sites, listed with the project.

SURGISTT 2, FORECAST and the other projects →

Legal framework and Summit

Legal support for international collaboration

  • Framework contracts
  • GISTT-RACE Foundation
  • Universitätsmedizin Essen
  • SARC

Program Committee GISTT-Summit 2027

Members to be announced.

Some people hold more than one role, so they appear in more than one place. Dashed boxes are still open.

The GISTT-RACE website develops along the way.